BLFS
BioLife Solutions Inc
38.60$
+2.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18.6% | 7.1% | -24.3% | 32.8% | 15.7% | – | 7.2% | 29.0% | 21.7% | 26.2% | -1.8% | 22.3% | 16.4% | |
| 13.9% | 7.3% | 12.4% | 12.0% | 7.6% | – | 5.8% | 5.4% | 4.8% | 3.1% | 2.5% | -2.5% | 1.9% | |
| 38.7% | 25.5% | 33.5% | 44.2% | 17.4% | – | 17.3% | 23.0% | 21.0% | 37.7% | 17.5% | -16.9% | 12.6% | |
| -8.1% | 16.0% | -14.3% | 16.4% | -1.9% | – | -15.7% | 0.3% | -10.6% | -11.9% | -25.0% | 24.2% | -5.1% | |
| 6.3% | 3.0% | 1.9% | 5.0% | 3.6% | – | 0.7% | 6.9% | 11.8% | 77.1% | 0.6% | 0.6% | 17.6% | |
| 7.1% | 12.1% | -1.2% | -68.1% | -5.5% | – | -113.5% | -155.5% | -21.3% | 6.1% | -6.7% | -5.5% | -8.0% | |
| – | – | – | – | -8.9% | – | -10.4% | -9.8% | -8.9% | -13.3% | -9.1% | -8.8% | -9.7% | |
| 2.6% | 30.1% | -5.2% | -3.6% | -3.4% | – | -12.5% | -11.3% | -9.1% | -13.3% | -28.7% | -12.6% | -16.1% | |
| -9.2% | 49.4% | -31.0% | -39.0% | 6.9% | – | -118.8% | -137.9% | -8.6% | 18.9% | -37.1% | 4.1% | -7.7% | |
| -24.9% | 4.1% | -26.2% | 27.7% | 12.1% | – | 6.5% | 22.1% | 10.0% | -50.9% | -2.4% | 22.9% | -0.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.